Concepedia

Stephen E. Wang

SE

2

Publications

166

Citations

2

H-Index

2017

Active since

Affiliations

Moffitt Cancer Center(Current)

Yale Cancer Center

The University of Texas MD Anderson Cancer Center

University of California, San Francisco

University of Colorado Denver

Stephen E. Wang is an author at Moffitt Cancer Center specializing in cancer therapeutics, radiation oncology, and pathology.

Top concepts

Publications per year

2017–2017

2

Publications

2

Randomized trial of irinotecan and cetuximab with or without vemurafenib in <i>BRAF</i>-mutant metastatic colorectal cancer (SWOG 1406).

Scott Kopetz, Shannon McDonough, Van K. Morris et al. · Journal of Clinical Oncology · 2017 · 107 citations

, , +15

Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406).

Scott Kopetz, Shannon McDonough, Heinz‐Josef Lenz et al. · Journal of Clinical Oncology · 2017 · 59 citations

, , +14

Rows per page

1–2 of 2